Krsnaa Diagnostics Ltd Faces Bearish Momentum Amid Technical Indicator Shifts

Technical Trend Overview

The technical trend for Krsnaa Diagnostics Ltd has deteriorated from mildly bearish to outright bearish, underscoring increasing selling pressure. The daily moving averages are firmly bearish, indicating that short-term price action is under strain. The stock closed at ₹552.50 on 15 Sep 2026, down 1.86% from the previous close of ₹562.95, with intraday trading ranging between ₹548.50 and ₹554.85. This price action remains closer to the 52-week low of ₹502.20 than the 52-week high of ₹891.80, signalling sustained weakness over the past year.

MACD and Momentum Indicators

The Moving Average Convergence Divergence (MACD) indicator presents a mixed picture. On a weekly basis, the MACD remains mildly bullish, suggesting some underlying momentum could support short-term rallies. However, the monthly MACD is bearish, reflecting longer-term downward momentum. This divergence between weekly and monthly MACD readings highlights the stock’s struggle to establish a sustained uptrend.

The Know Sure Thing (KST) indicator echoes this sentiment, showing mild bullishness on the weekly chart but bearishness on the monthly timeframe. Such conflicting signals often indicate consolidation or a potential inflection point, but in Krsnaa Diagnostics’ case, the prevailing trend remains negative.

Relative Strength Index (RSI) and Bollinger Bands

The RSI on the weekly chart is bearish, indicating that the stock is experiencing downward momentum and may be approaching oversold conditions. The monthly RSI, however, does not provide a clear signal, suggesting a lack of strong directional conviction over the longer term.

Bollinger Bands reinforce the bearish outlook, with both weekly and monthly bands signalling downward pressure. The stock price is trading near the lower band on the weekly chart, which could imply short-term oversold conditions but also highlights persistent weakness.

On-Balance Volume (OBV) and Dow Theory

Volume-based indicators add further nuance. The weekly OBV is mildly bearish, indicating that volume trends are not supporting price advances. The monthly OBV shows no clear trend, reflecting uncertainty among investors over the longer horizon.

Dow Theory assessments reveal no clear trend on the weekly scale, while the monthly perspective is mildly bullish. This suggests that while short-term price action is weak, there may be some underlying accumulation or positive sentiment developing over several months, though this has yet to translate into a meaningful price recovery.

Price Performance Relative to Sensex

Krsnaa Diagnostics Ltd’s price returns have lagged significantly behind the Sensex across multiple timeframes. Over the past week, the stock declined by 1.21%, outperforming the Sensex’s 2.27% fall, but this short-term relative strength is overshadowed by longer-term underperformance. The one-month return stands at -3.95% versus the Sensex’s -4.32%, while year-to-date losses are a steep -23.3% compared to the Sensex’s -12.25%.

Over the last year, the stock has plunged 34.31%, markedly worse than the Sensex’s 8.30% decline. The three-year and five-year returns are also deeply negative at -18.16% and -38.39%, respectively, while the Sensex posted gains of 11.40% and 28.26% over the same periods. This persistent underperformance reflects structural challenges and investor scepticism about the company’s growth prospects within the healthcare services sector.

Mojo Score and Market Capitalisation

Krsnaa Diagnostics holds a Mojo Score of 31.0, categorised as a Sell rating, which was downgraded from a Strong Sell on 6 February 2026. This score reflects the company’s small-cap status and the prevailing bearish technical signals. The downgrade indicates a deterioration in the stock’s quality and momentum metrics, signalling caution for investors considering exposure to this healthcare services player.

Moving Averages and Daily Price Action

The daily moving averages are firmly bearish, with the stock trading below its key short-term and medium-term averages. This alignment suggests that the immediate price momentum is negative, and any rallies may face resistance near these moving average levels. The intraday trading range on 15 September 2026, between ₹548.50 and ₹554.85, shows limited volatility but a downward bias.

Outlook and Investor Considerations

While some weekly indicators such as MACD and KST hint at mild bullishness, the overwhelming monthly and daily signals remain bearish. The stock’s technical deterioration, combined with its sustained underperformance relative to the Sensex and sector peers, suggests that investors should exercise caution. The current Mojo Grade of Sell aligns with this view, reflecting both fundamental and technical headwinds.

Investors should closely monitor whether the stock can break above its moving averages and improve volume trends to signal a potential reversal. Until then, the risk of further downside remains elevated, particularly given the small-cap nature of Krsnaa Diagnostics and the volatility inherent in healthcare services stocks.

Summary

Krsnaa Diagnostics Ltd’s technical parameters have shifted towards a more bearish stance, with daily moving averages and monthly momentum indicators signalling continued weakness. Despite some mildly bullish weekly signals, the stock’s price momentum remains under pressure, compounded by poor relative returns versus the Sensex and a downgraded Mojo Grade of Sell. Investors should remain cautious and consider alternative opportunities until a clear technical turnaround is confirmed.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →